US National Institutes of Health Director Francis Collins is appropriately cautious in setting expectations for a new public-private partnership intended to streamline development of potential COVID-19 therapeutics and vaccines.
“Will we be at the point by July or August that we have demonstrated 1 or 2 or 3 therapeutics that are effective in RCTs? I hope so,” Collins said...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?